I'm looking for

Actively and Aggressively Advocating for the Gynecologic Oncology Subspecialty and Our Patients

As oncology professionals, we know very well how rapidly things change. Events can overtake intentions and regulations can overturn precedent. At the Society of Gynecologic Oncology (SGO), our member-led teams work to create data-driven, ethics-forward and practical policies on anything that impacts our field.

Check this space for information on political developments, technological innovations and more.

Future of Physician Payment Reform

The primary responsibility of the Future of Physician Payment Reform Legislative and Regulatory Affairs Task Force is to monitor the ongoing transition from a fee-for-service system to a value-based system and ensure gynecologic oncology can deliver high-quality and cost-effective care. The task force considers forward-thinking practice models for physician payment, policies that support SGO members and address multidisciplinary practice management issues that impact the care of people with gynecologic malignancies.

This task force strives to fulfill the recommendations put forth in the white paper, Creating a New Paradigm in Gynecologic Cancer Care: Policy Proposals for Delivery, Quality and Reimbursement, published in February 2013.

aboutsgo
nurses-working-at-station

Coding and Reimbursement

The Coding and Reimbursement Task Force’s primary purpose is to represent the interest of gynecologic oncologists regarding regulatory and other issues that impact coding, billing and reimbursement. They provide expertise to the Legislative and Regulatory Committee regarding reimbursement issues, and manage proposals for new and revised current procedural (CPT) codes through its partnership with the American College of Obstetricians and Gynecologists (ACOG) and its visibility within the American Medical Association (AMA) CPT Editorial Panel-sponsored national committees.

Legislative and Regulatory Affairs

The primary responsibilities of the Legislative and Regulatory Affairs Task Force is to monitor legislative and regulatory activity at the national level and communicate information to other appropriate task forces within the Health Policy and Socio-economic Committee. This work group ensures policies enacted and implemented by government are favorable to SGO members, determines SGO’s involvement in issue-specific coalitions and supports continuation of the Ovarian Cancer Research Program at the Department of Defense.

Interested participating in these initiatives?

Join the SGO Congressional Ambassadors Program

practicemanagement
Advertisement

Join SGO Today

What you get out of membership changes your patient’s lives. What you give from your membership changes the world. Join your community today.

Become a Member

Recent Position Statements

With health care a constant political issue and technology overtaking even our imaginations, staying ahead of developments is more important than ever.

Jun 2, 2020

SGO Statement on Racism and Violence

Type: Position Statements
Type: Health Equity
Oct 1, 2016

Opioid Use in Gynecology Oncology; Balancing Efficacy, Accessibility and Safety: An SGO Clinical Practice Statement

Type: Position Statements
Type: Health Policy
Oct 1, 2016

Position Statement on Pelvic Examinations

Type: Position Statements
Type: Pelvic Examinations
Oct 1, 2014

Genetic Testing for Gynecologic Cancer

Type: Position Statements
Type: Genetics
Dec 1, 2013

SGO Position Statement: Morcellation

Type: Position Statements
Type: Morcellation
Dec 1, 2013

HPV Vaccination of Girls and Boys

Type: Position Statements
Type: Cervical CancerHPV
May 1, 2013

Multiplex Serum Testing for Women with Pelvic Mass

Type: Position Statements
Type: Ovarian Cancer
Mar 1, 2012

Cervical Cancer Screening Recommendations

Type: Position Statements
Type: Cervical Cancer
Jun 1, 2011

OCEANS Study Results

Type: Position Statements
Type: Ovarian Cancer
May 1, 2011

Role of HPV Testing and HPV Typing in Cervical Cancer Prevention and Detection

Type: Position Statements
Type: Cervical CancerHPV
Sep 1, 2010

Delivery of Palliative Care Services

Type: Position Statements
Type: Palliative Care
Jun 1, 2010

GOG 218 Phase III Trial Study Results

Type: Position Statements
Type: Ovarian Cancer
Jun 1, 2009

Use of CA125 for Monitoring Ovarian Cancer

Type: Position Statements
Type: Ovarian Cancer
Jun 1, 2010

Use of CA125 in Screening for Ovarian Cancer

Type: Position Statements
Type: Ovarian Cancer